Clinical Trial Update: S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing S-1 plus oxaliplatin versus S-1 plus cisplatin as first-line therapy for advanced or recurrent non-intestinal type gastric adenocarcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Platinol (cisplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED